/  News 

Meeting of Influenza Vaccine and Diagnostic Strains Committee, March 12, 2012

March 12, 2012 — Meeting of Influenza Vaccine and Diagnostic Strains Committee took place at the RII. The members of the Committee discussed the latest WHO recommendations on the composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season and the regulatory documents concerning procedure for yearly vaccine composition updating in Russia. It was recommended:

To replace the following strains used for the previous (2011–2012) season’s live and inactivated influenza vaccines and diagnostic reagents:

  • an A/Perth/16/2009 (H3N2)–like virus;
  • a B/Brisbane/60/2008–like virus (Victoria lineage).

To include the following strains into composition of influenza vaccines and diagnostic reagents for the season 2012-2013:

  • an A/California/7/2009 (H1N1)pdm09-like virus;
  • an A/Victoria/361/2011 (H3N2)-like virus;
  • a B/Wisconsin/1/2010-like virus (Yamagata lineage).

Back to list